Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence
Condition(s):MelanomaLast Updated:October 4, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):MelanomaLast Updated:October 4, 2022Not yet recruiting
Condition(s):PsoriasisLast Updated:January 18, 2024Completed
Condition(s):Basal Cell CarcinomaLast Updated:October 14, 2020Completed
Condition(s):Lichen PlanusLast Updated:February 15, 2022Completed
Condition(s):Bullous PemphigoidLast Updated:August 30, 2017Unknown status
Condition(s):Cutaneous Atrophy Due to CorticosteroidsLast Updated:July 3, 2015Completed
Condition(s):Pressure UlcersLast Updated:September 29, 2010Completed
Condition(s):Chronic Leg UlcersLast Updated:February 25, 2015Completed
Condition(s):Lyme BorreliosisLast Updated:June 30, 2022Active, not recruiting
Condition(s):Drug Hypersensitivity; DRESS SyndromeLast Updated:September 21, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.